Healthcare Asia Summit - March 25, 2026
Register Now
Sponsors & Exhibitors
Overview Healthcare Asia Summit 2026
As Asia moves toward a more connected and technology-driven future, Healthcare Asia presents the Healthcare Asia Summit 2026, a platform that unites healthcare leaders, policymakers, and innovators to redefine how care is delivered, financed, and sustained across the region.
Under the theme “Connected Care, Smarter Systems: Shaping Asia’s Next Health Transformation,” this year’s summit explores how healthcare systems are breaking silos to build truly interoperable, secure, and patient-centered ecosystems. Discussions will span real-world AI applications, data governance, workforce readiness, and the evolution of digital hospitals and financing models shaping tomorrow’s care.
Join us on 25 March 2026 and gain actionable insights from Asia’s most forward-thinking health leaders driving smarter, safer, and more inclusive healthcare.
Why the Healthcare Asia Summit 2026 is the must-attend event:
CONNECT
Engage with healthcare visionaries and decision-makers across Asia. Exchange ideas, forge collaborations, and gain perspectives on how to strengthen healthcare networks and systems integration.
INNOVATE
Discover how AI, data interoperability, and smart financing are transforming patient outcomes and operational efficiency. Learn from Asia’s leading innovators building the digital hospitals, sustainable models, and connected systems of the future.
SPEAKERS
Hiang Khoon Tan
Chief Executive Officer
Singapore General Hospital
Chief Executive Officer
Singapore General Hospital
Clinical Associate Professor Tan Hiang Khoon is a dynamic clinician leader who is currently serving as the CEO Singapore General Hospital. His career trajectory includes several key leadership roles within SingHealth. From 2021 to 2024, he served concurrently as Group Director of the International Collaboration Office (ICO) at SingHealth and Director of the SingHealth Duke-NUS Global Health Institute (SDGHI). Additionally, he took on the role of Deputy CEO (Future Health System), SGH from 2022 to 2024. Prior to these appointments, Dr Tan was the Chair of Surgery from 2015 to 2022.
With a distinguished career in head and neck surgery and surgical oncology, Dr Tan has made significant strides in healthcare leadership. He spearheaded the creation of the SingHealth Duke-NUS Head and Neck Disease Centre in 2013. As Chair of surgery, he led the integration of the Division of Surgery at Singapore General Hospital with the Division of Surgical Oncology at the National Cancer Centre Singapore to optimise care of surgical patients. Notably, during the COVID-19 pandemic, he established a 3,700-bed Community Care Facility, ensuring hospital capacities were maintained.
Dr Tan is dedicated to global health equity; he founded the Global Surgery Programme and initiated the Asian Surgical Leaders Network, which addresses the pandemic's impact on surgical health systems in Asia and develops strategies for health system resilience. His commitment to cost-conscious innovation led to a partnership with Duke University, resulting in a low-cost portable flexible nasopharyngoscope, enhancing diagnostic access in lower-resourced settings.
Dr Tan holds a medical degree from the National University of Singapore, a Ph.D. from the University of Bristol, and advanced training in head and neck surgical oncology from the Institute Gustave Roussy in Paris. He also earned an Executive Master in Business Administration from the National University of Singapore.
Sponsors
AGENDA
*subject to change
8:30 - 9:00 AM REGISTRATION
9:15 - 9:20 AM Welcome Remarks
- Tim Charlton, Publisher, Healthcare Asia
9:20 - 9:35 AM Opening Speaker
9:35 - 9:55 AM Keynote Speaker
9:55 - 10:15 AM CEO Fireside Chat
10:15 -10:45 AM Panel Session 1
10:45 - 11:25 AM NETWORKING BREAK
11:25 - 11:45 AM Speaker 4
11:45 - 12:05 AM Speaker 5
12:05 - 12:35 PM Panel Session 2
12:35 - 2:00 PM MIDDAY BREAK
2:00 - 2:20 PM Speaker 6
2:20 - 2:40 PM CEO Fireside Chat
- Hiang Khoon Tan, Chief Executive Officer, Singapore General Hospital
2:40 - 3:00 PM Speaker 8
3:00 - 3:30 PM NETWORKING BREAK
3:30 - 3:50 PM Speaker 9
3:50 - 4:10 PM Speaker 10
4:10 - 4:40 PM Panel Session 3
5:00 PM END OF PROGRAM
For inquiries, reach us at
For more details, contact:
Healthcare Asia Events Team
+65 31581386
SPEAKERS
Hiang Khoon Tan
Chief Executive Officer
Singapore General Hospital
Chief Executive Officer
Singapore General Hospital
Clinical Associate Professor Tan Hiang Khoon is a dynamic clinician leader who is currently serving as the CEO Singapore General Hospital. His career trajectory includes several key leadership roles within SingHealth. From 2021 to 2024, he served concurrently as Group Director of the International Collaboration Office (ICO) at SingHealth and Director of the SingHealth Duke-NUS Global Health Institute (SDGHI). Additionally, he took on the role of Deputy CEO (Future Health System), SGH from 2022 to 2024. Prior to these appointments, Dr Tan was the Chair of Surgery from 2015 to 2022.
With a distinguished career in head and neck surgery and surgical oncology, Dr Tan has made significant strides in healthcare leadership. He spearheaded the creation of the SingHealth Duke-NUS Head and Neck Disease Centre in 2013. As Chair of surgery, he led the integration of the Division of Surgery at Singapore General Hospital with the Division of Surgical Oncology at the National Cancer Centre Singapore to optimise care of surgical patients. Notably, during the COVID-19 pandemic, he established a 3,700-bed Community Care Facility, ensuring hospital capacities were maintained.
Dr Tan is dedicated to global health equity; he founded the Global Surgery Programme and initiated the Asian Surgical Leaders Network, which addresses the pandemic's impact on surgical health systems in Asia and develops strategies for health system resilience. His commitment to cost-conscious innovation led to a partnership with Duke University, resulting in a low-cost portable flexible nasopharyngoscope, enhancing diagnostic access in lower-resourced settings.
Dr Tan holds a medical degree from the National University of Singapore, a Ph.D. from the University of Bristol, and advanced training in head and neck surgical oncology from the Institute Gustave Roussy in Paris. He also earned an Executive Master in Business Administration from the National University of Singapore.